Prostate cancer vaccine - United Biomedical

Drug Profile

Prostate cancer vaccine - United Biomedical

Alternative Names: LHRH vaccine - United Biomedical; SUIS-LHRH

Latest Information Update: 18 Oct 2002

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator United Biomedical
  • Class Cancer vaccines
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Prostate cancer

Most Recent Events

  • 18 Oct 2002 No development reported - Phase-I for Prostate cancer in USA (unspecified route)
  • 01 Dec 1998 Phase-I clinical trials for Prostate cancer in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top